Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101 Barginear, Myra , Dueck, Amylou C. , Allred, Jacob B. ... - - Oncologist - 2019 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A151411 , CALGB-40101 , CALGB-70301
Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715) Dao, Dyda , Zemla, Tyler , Jatoi, Aminah , Freedman, Rachel A. ... - - Oncologist - 2019 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A151715 , CALGB-49907 , CALGB-40401
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602) Freedman, Rachel A. , Dockter, Travis J. , Lafky, Jacqueline M. ... - - Oncologist - 2018 Manuscript - Primary Endpoint - Primary Analysis - Older Adult - A171602
Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial George, Daniel J. , Hessel, Colin , Halabi, Susan ... - - Oncologist - 2019 Manuscript - Secondary Endpoint - Primary Analysis - GU - A031203
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance) Halfdanarson, Thorvardur R. , Foster, Nathan R. , Kim, George P. ... - - Oncologist - 2019 Manuscript - Primary Endpoint - Primary Analysis - GI - N064B
Tumor Status at 12 Weeks Predicts Survival in Advanced Colorectal Cancer: Findings from NCCTG N9741 Heun, James M. , Grothey, Axel , Branda, Megan E. ... - - Oncologist - 2011 Manuscript - Secondary Endpoint - Primary Analysis - GI - NCCTG-N9741
Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4) Jatoi, Aminah , Thrower, Abby , Sloan, Jeff A. , Flynn, Patrick J. ... - - Oncologist - 2010 Manuscript - Primary Endpoint - Primary Analysis - Prevention - N05C4
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803 Niedzwiecki, Donna , Hasson, Rian M. , Lenz, Heinz‐Josef ... - - Oncologist - 2017 Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - GI - C89803 , C9581
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603) O'Reilly, Eileen M. , Niedzwiecki, Donna , Hall, Margaret ... - - Oncologist - 2010 Manuscript - Primary Endpoint - Primary Analysis - GI - CALGB-80603
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance). Parikh, Kaushal , Mandrekar, Sumithra J , Allen-Ziegler, Katie ... - - Oncologist - 2019 Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0623
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance) Singh, Preet Paul , Shi, Qian , Foster, Nathan R. , Grothey, Axel ... - - Oncologist - 2016 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - GI - NCCTG-N0147
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance) Vera Aguilera, Jesus , Rao, Ravi D. , Allred, Jacob B. ... - - Oncologist - 2018 Manuscript - Primary Endpoint - Primary Analysis - Experimental - N0377
Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials Wang, Xiaofei , Wang, Xiaoyi , Hodgson, Lydia , George, Stephen L. ... - - Oncologist - 2017 Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - C8435 , C8638 , C8833 , C8933 , C9031 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , N0021 , NCCTG-N0623
